| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/08/2001 | WO2001009162A2 Secreted proteins and uses thereof |
| 02/08/2001 | WO2001009161A1 Drug target isogenes: polymorphisms in the solute carrier family 6_neurotransmitter transporter, serotonin_, member 4 gene |
| 02/08/2001 | WO2001009156A1 HIGH AFFINITY TGFη NUCLEIC ACID LIGANDS AND INHIBITORS |
| 02/08/2001 | WO2001009155A1 Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones |
| 02/08/2001 | WO2001009150A2 Compositions and methods to enhance sensitivity of cancer cells to mitotic stress |
| 02/08/2001 | WO2001008720A2 Hypocretin and hypocretin receptors in regulation of sleep and related disorders |
| 02/08/2001 | WO2001008708A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 02/08/2001 | WO2001008703A1 Recombinant rsv virus expression systems and vaccines |
| 02/08/2001 | WO2001008702A2 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 02/08/2001 | WO2001008700A1 Preventing immune-mediated abortion by inhibiting costimulation |
| 02/08/2001 | WO2001008677A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | WO2001008636A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 02/08/2001 | WO2001008635A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | WO2001008486A1 CoaA POLYPEPTIDES AND POLYNUCLEOTIDES AND METHODS THEREOF |
| 02/08/2001 | WO2000076540A3 Streptococcus pneumoniae proteins and vaccines |
| 02/08/2001 | WO2000075317A3 Compositions and methods for the treatment of tumor |
| 02/08/2001 | WO2000075310A8 Interleukin-1-receptor associated kinase-3 (irak3) |
| 02/08/2001 | WO2000069894A3 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 02/08/2001 | WO2000069456A3 Adjuvant combination formulations |
| 02/08/2001 | WO2000069449A3 Conditioned cell culture medium compositions and methods of use |
| 02/08/2001 | WO2000068405A3 Plant defensins |
| 02/08/2001 | WO2000068261A3 Attenuated microorganisms for the treatment of infection |
| 02/08/2001 | WO2000067700A3 Recombinant vaccine against botulinum neurotoxin |
| 02/08/2001 | WO2000065039A3 Identification of dna control elements responsive to specific stimuli |
| 02/08/2001 | WO2000065026A3 YycG |
| 02/08/2001 | WO2000063426A3 Compound screening methods |
| 02/08/2001 | WO2000063406A3 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |
| 02/08/2001 | WO2000063247A3 Osteopontin-derived chemotactic and inhibitory agents and uses therefor |
| 02/08/2001 | WO2000063230A3 49 human secreted proteins |
| 02/08/2001 | WO2000061772A3 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/08/2001 | WO2000061768A3 Preparation of biologically active molecules |
| 02/08/2001 | WO2000061756A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 02/08/2001 | WO2000058471A3 Multidrug resistance associated proteins and uses thereof |
| 02/08/2001 | WO2000053758A3 Compositions and methods for the treatment of immune related diseases |
| 02/08/2001 | WO2000053755A3 Compositions and methods for the treatment of tumor |
| 02/08/2001 | WO2000050455A3 Antigen to systemic lupus erythematosis and diagnostic assay |
| 02/08/2001 | WO2000030672A8 Collagen based biomaterials and methods of preparation and use |
| 02/08/2001 | WO2000011150A8 Cell surface immunomodulators |
| 02/08/2001 | DE19937230A1 Chimäre Proteine Chimeric proteins |
| 02/08/2001 | DE19936563A1 Tumorassoziiertes Antigen Tumor-associated antigen |
| 02/08/2001 | DE19935086A1 DNA-Sequenzen, die Typ II (xcp) Sekretionssysteme kodieren DNA sequences encoding type II (xcp) secretion |
| 02/08/2001 | DE19904800C1 Partikel zur Gentherapie Particles for gene therapy |
| 02/08/2001 | DE10019006A1 Neuartiger adenoviraler Vektor für den Gentransfer, seine Anwendung und seine Herstellung Novel adenoviral vector for gene transfer, its application and its preparation |
| 02/08/2001 | CA2820314A1 Vaccine composition |
| 02/08/2001 | CA2820271A1 Vaccine composition |
| 02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 02/08/2001 | CA2647796A1 Method of inhibiting osteoclast activity |
| 02/08/2001 | CA2391682A1 Novel uses of abca-type transporters |
| 02/08/2001 | CA2391348A1 Enhanced delivery via serpin enzyme complex receptor |
| 02/08/2001 | CA2390371A1 Antibiotics based upon bacteriophage lysis proteins |
| 02/08/2001 | CA2388663A1 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | CA2381565A1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 02/08/2001 | CA2381437A1 G-protein coupled receptor and dna sequences thereof |
| 02/08/2001 | CA2380840A1 Vaccine composition |
| 02/08/2001 | CA2380837A1 High affinity tgf.beta. nucleic acid ligands and inhibitors |
| 02/08/2001 | CA2380831A1 Moraxella catarrhalis antigen basb117 |
| 02/08/2001 | CA2380825A1 Basb116 dna and proteins from moraxella catarrhalis |
| 02/08/2001 | CA2380822A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380819A1 Basb120 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380813A1 Human monoclonal antibodies to her2/neu |
| 02/08/2001 | CA2380803A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380799A1 Rescue of mumps virus from cdna |
| 02/08/2001 | CA2380639A1 Cloning of the <i>streptomyces avermitilis</i> genes for glycosylation of avermectin aglycones |
| 02/08/2001 | CA2380631A1 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | CA2380573A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | CA2380518A1 Novel compounds |
| 02/08/2001 | CA2380515A1 Polypeptides and polynucleotides from moraxella catarrhalis |
| 02/08/2001 | CA2380514A1 Attenuated influenza virus useful as vaccine |
| 02/08/2001 | CA2380507A1 Compositions and methods to enhance sensitivity of cancer cells to mitotic stress |
| 02/08/2001 | CA2380506A1 Novel compounds |
| 02/08/2001 | CA2380501A1 Novel compounds |
| 02/08/2001 | CA2380498A1 Novel compounds |
| 02/08/2001 | CA2380473A1 Tenascin-c nucleic acid ligands |
| 02/08/2001 | CA2380472A1 Gene specifically expressed in human fetal cardiac muscle |
| 02/08/2001 | CA2380428A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | CA2380354A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 02/08/2001 | CA2380351A1 Basb126 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | CA2380108A1 Recombinant rsv virus expression systems and vaccines |
| 02/08/2001 | CA2380018A1 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 02/08/2001 | CA2380007A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | CA2379963A1 Mammalian cytokines; related reagents |
| 02/08/2001 | CA2379819A1 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378441A1 Plant defensin variants with modified systein residues |
| 02/08/2001 | CA2378432A1 Proteins and peptides |
| 02/08/2001 | CA2378331A1 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | CA2378182A1 Compositions and methods for the treatment of tumors |
| 02/08/2001 | CA2378168A1 Moraxella catarrhalis antigens basb122 and basb124 |
| 02/08/2001 | CA2377064A1 Purine metabolism genes in plants |
| 02/08/2001 | CA2374743A1 Human chaperone proteins |
| 02/07/2001 | EP1074842A1 Catalytic anti-factor VIII allo-antibodies |
| 02/07/2001 | EP1074625A2 DNA vaccine against feline immunodeficiency virus |
| 02/07/2001 | EP1074624A1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 02/07/2001 | EP1074623A1 ABC transporter |
| 02/07/2001 | EP1074622A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF |
| 02/07/2001 | EP1074621A1 Human tsc403 gene and human ing1l gene |
| 02/07/2001 | EP1074620A1 Monomeric protein of the TGF-beta family |
| 02/07/2001 | EP1074619A2 Promoter for neuropeptide FF and use thereof for therapy and diagnostics |
| 02/07/2001 | EP1074618A2 Cadherin materials and methods |